Voya Financial Advisors, Inc. Galapagos Nv Transaction History

Voya Financial Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$122.47 - $213.56 $339,609 - $592,201	-2,773 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$185.52 - $231.25 $12,986 - $16,187	70 Added 2.59%	2,773 $545,000
Q1 2020 May 15, 2020	BUY	$143.0 - $274.03 $51,623 - $98,924	361 Added 15.41%	2,703 $515,000
Q4 2019 Feb 14, 2020	BUY	$146.12 - $215.82 $18,995 - $28,056	130 Added 5.88%	2,342 $488,000
Q3 2019 Nov 14, 2019	BUY	$130.44 - $187.64 $12,652 - $18,201	97 Added 4.59%	2,212 $340,000
Q2 2019 Aug 14, 2019	BUY	$111.45 - $128.93 $235,716 - $272,686	2,115 New	2,115 $270,000

17.4M

10.4K

33.1K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.77B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Voya Financial Advisors, Inc. with notifications on news.